Osteoprotegerin abrogated cortical porosity and bone marrow fibrosis in a mouse model of constitutive activation of the PTH/PTHrP receptor. [electronic resource]
Producer: 20090623Description: 2160-71 p. digitalISSN:- 1525-2191
- Alendronate -- pharmacology
- Animals
- Biomechanical Phenomena
- Bone Resorption -- metabolism
- Bone and Bones -- drug effects
- Diphosphonates -- pharmacology
- Disease Models, Animal
- Humans
- Hyperparathyroidism -- metabolism
- Imidazoles -- pharmacology
- Immunohistochemistry
- Male
- Mice
- Mice, Transgenic
- Osteoclasts -- drug effects
- Osteoprotegerin -- metabolism
- Porosity
- Primary Myelofibrosis -- metabolism
- Receptor, Parathyroid Hormone, Type 1 -- genetics
- Tomography, X-Ray Computed
- Zoledronic Acid
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.